As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill
Coverage (2)
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
A breakthrough blood test promises earlier Alzheimer’s diagnosis, yet patients grapple with rising confusion and distress.
Column | 3 minutes of this activity may cut the risk of 13 cancers, study finds
A three‑minute burst of vigorous movement could slash the odds of thirteen cancers, upending the idea that only long workouts protect health.
Fact check: Trump makes numerous false and misleading claims about vaccines and autism
Recent coverage fact-checks numerous false vaccine and autism claims pushed by Donald Trump.
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.